Type |
Details |
Score |
GXD Expression |
Probe: |
MGI:6172904 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Absent |
Sex: |
Male |
Emaps: |
EMAPS:1689428 |
|
Stage: |
TS28 |
Assay Id: |
MGI:6190279 |
Age: |
postnatal day 4 |
|
|
Specimen Label: |
Table S2 - P4 - Fgfr4 |
Detected: |
false |
Specimen Num: |
5 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6172904 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Absent |
Sex: |
Male |
Emaps: |
EMAPS:1689428 |
|
Stage: |
TS28 |
Assay Id: |
MGI:6190279 |
Age: |
postnatal day 14 |
|
|
Specimen Label: |
Table S2 - P14 - Fgfr4 |
Detected: |
false |
Specimen Num: |
6 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6172904 |
Assay Type: |
RNA in situ |
Annotation Date: |
2018-07-25 |
Strength: |
Absent |
Sex: |
Male |
Emaps: |
EMAPS:1689428 |
|
Stage: |
TS28 |
Assay Id: |
MGI:6190279 |
Age: |
postnatal day 28 |
|
|
Specimen Label: |
Table S2 - P28 - Fgfr4 |
Detected: |
false |
Specimen Num: |
7 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6514773 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2021-04-02 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1689420 |
Pattern: |
Regionally restricted |
Stage: |
TS20 |
Assay Id: |
MGI:6514794 |
Age: |
embryonic day 12.5 |
|
Note: |
Expression in periventricular central nervous system tissue. |
Specimen Label: |
E12.5 not shown |
Detected: |
true |
Specimen Num: |
4 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6514773 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2021-04-02 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:1689423 |
|
Stage: |
TS23 |
Assay Id: |
MGI:6514794 |
Age: |
embryonic day 15.5 |
|
Note: |
No expression in periventricular central nervous system tissue. |
Specimen Label: |
E15.5 not shown |
Detected: |
false |
Specimen Num: |
5 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6514773 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2021-04-02 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:1689426 |
|
Stage: |
TS26 |
Assay Id: |
MGI:6514794 |
Age: |
embryonic day 18.5 |
|
Note: |
No expression in periventricular central nervous system tissue. |
Specimen Label: |
E18.5 not shown |
Detected: |
false |
Specimen Num: |
6 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6511121 |
Assay Type: |
RNA in situ |
Annotation Date: |
2021-03-19 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1707420 |
Pattern: |
Not Specified |
Stage: |
TS20 |
Assay Id: |
MGI:6511221 |
Age: |
embryonic day 12.5 |
|
|
Specimen Label: |
Table 1 E12.5 |
Detected: |
true |
Specimen Num: |
5 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6511121 |
Assay Type: |
RNA in situ |
Annotation Date: |
2021-03-19 |
Strength: |
Strong |
Sex: |
Not Specified |
Emaps: |
EMAPS:1707420 |
Pattern: |
Not Specified |
Stage: |
TS20 |
Assay Id: |
MGI:6511221 |
Age: |
embryonic day 12.5 |
Image: |
7M |
|
Specimen Label: |
7M |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6511121 |
Assay Type: |
RNA in situ |
Annotation Date: |
2021-03-19 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:3521728 |
|
Stage: |
TS28 |
Assay Id: |
MGI:6511221 |
Age: |
postnatal day 21 |
|
|
Specimen Label: |
Table 1 P21 |
Detected: |
false |
Specimen Num: |
9 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5001994 |
Assay Type: |
RNA in situ |
Annotation Date: |
2014-02-07 |
Strength: |
Absent |
Sex: |
Female |
Emaps: |
EMAPS:1796223 |
|
Stage: |
TS23 |
Assay Id: |
MGI:5542548 |
Age: |
embryonic day 15.5 |
Image: |
GUDMAP:10649 |
|
Specimen Label: |
GUDMAP:10649 |
Detected: |
false |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3766801 |
Assay Type: |
RNA in situ |
Annotation Date: |
2012-06-12 |
Strength: |
Moderate |
Sex: |
Not Specified |
Emaps: |
EMAPS:1768022 |
Pattern: |
Regionally restricted |
Stage: |
TS22 |
Assay Id: |
MGI:5421728 |
Age: |
embryonic day 14.5 |
Image: |
FG37; Specimen EX216 |
Note: |
Expression was detected in the skull (base and vault). |
Specimen Label: |
FG37; Specimen EX216 |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:3766801 |
Assay Type: |
RNA in situ |
Annotation Date: |
2012-06-12 |
Strength: |
Weak |
Sex: |
Not Specified |
Emaps: |
EMAPS:2672022 |
Pattern: |
Regionally restricted |
Stage: |
TS22 |
Assay Id: |
MGI:5421728 |
Age: |
embryonic day 14.5 |
Image: |
FG37; Specimen EX216 |
Note: |
Expression was weak in whisker follicle. |
Specimen Label: |
FG37; Specimen EX216 |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5615918 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2015-02-18 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:2672028 |
|
Stage: |
TS28 |
Assay Id: |
MGI:5615931 |
Age: |
postnatal |
|
|
Specimen Label: |
wild-type |
Detected: |
false |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5615918 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2015-02-18 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:2672028 |
|
Stage: |
TS28 |
Assay Id: |
MGI:5615931 |
Age: |
postnatal |
Image: |
-/- |
|
Specimen Label: |
-/- |
Detected: |
false |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:4416018 |
Assay Type: |
RNA in situ |
Annotation Date: |
2010-09-14 |
Strength: |
Moderate |
Sex: |
Not Specified |
Emaps: |
EMAPS:1625523 |
Pattern: |
Regionally restricted |
Stage: |
TS23 |
Assay Id: |
MGI:4824849 |
Age: |
embryonic day 14.5 |
Image: |
euxassay_010371_10 |
|
Specimen Label: |
euxassay_010371_10 |
Detected: |
true |
Specimen Num: |
10 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:4416018 |
Assay Type: |
RNA in situ |
Annotation Date: |
2010-09-14 |
Strength: |
Weak |
Sex: |
Not Specified |
Emaps: |
EMAPS:1625523 |
Pattern: |
Regionally restricted |
Stage: |
TS23 |
Assay Id: |
MGI:4824849 |
Age: |
embryonic day 14.5 |
Image: |
euxassay_010371_11 |
|
Specimen Label: |
euxassay_010371_11 |
Detected: |
true |
Specimen Num: |
11 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:4416018 |
Assay Type: |
RNA in situ |
Annotation Date: |
2010-09-14 |
Strength: |
Weak |
Sex: |
Not Specified |
Emaps: |
EMAPS:1625523 |
Pattern: |
Regionally restricted |
Stage: |
TS23 |
Assay Id: |
MGI:4824849 |
Age: |
embryonic day 14.5 |
Image: |
euxassay_010371_12 |
|
Specimen Label: |
euxassay_010371_12 |
Detected: |
true |
Specimen Num: |
12 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:4416018 |
Assay Type: |
RNA in situ |
Annotation Date: |
2010-09-14 |
Strength: |
Moderate |
Sex: |
Not Specified |
Emaps: |
EMAPS:1625523 |
Pattern: |
Regionally restricted |
Stage: |
TS23 |
Assay Id: |
MGI:4824849 |
Age: |
embryonic day 14.5 |
Image: |
euxassay_010371_13 |
|
Specimen Label: |
euxassay_010371_13 |
Detected: |
true |
Specimen Num: |
13 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:4416018 |
Assay Type: |
RNA in situ |
Annotation Date: |
2010-09-14 |
Strength: |
Moderate |
Sex: |
Not Specified |
Emaps: |
EMAPS:1625523 |
Pattern: |
Regionally restricted |
Stage: |
TS23 |
Assay Id: |
MGI:4824849 |
Age: |
embryonic day 14.5 |
Image: |
euxassay_010371_14 |
|
Specimen Label: |
euxassay_010371_14 |
Detected: |
true |
Specimen Num: |
14 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:4416018 |
Assay Type: |
RNA in situ |
Annotation Date: |
2010-09-14 |
Strength: |
Moderate |
Sex: |
Not Specified |
Emaps: |
EMAPS:1625523 |
Pattern: |
Regionally restricted |
Stage: |
TS23 |
Assay Id: |
MGI:4824849 |
Age: |
embryonic day 14.5 |
Image: |
euxassay_010371_15 |
|
Specimen Label: |
euxassay_010371_15 |
Detected: |
true |
Specimen Num: |
15 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:4416018 |
Assay Type: |
RNA in situ |
Annotation Date: |
2010-09-14 |
Strength: |
Moderate |
Sex: |
Not Specified |
Emaps: |
EMAPS:1625523 |
Pattern: |
Regionally restricted |
Stage: |
TS23 |
Assay Id: |
MGI:4824849 |
Age: |
embryonic day 14.5 |
Image: |
euxassay_010371_16 |
|
Specimen Label: |
euxassay_010371_16 |
Detected: |
true |
Specimen Num: |
16 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:4416018 |
Assay Type: |
RNA in situ |
Annotation Date: |
2010-09-14 |
Strength: |
Moderate |
Sex: |
Not Specified |
Emaps: |
EMAPS:1625523 |
Pattern: |
Regionally restricted |
Stage: |
TS23 |
Assay Id: |
MGI:4824849 |
Age: |
embryonic day 14.5 |
Image: |
euxassay_010371_17 |
|
Specimen Label: |
euxassay_010371_17 |
Detected: |
true |
Specimen Num: |
17 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6514773 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2021-04-02 |
Strength: |
Strong |
Sex: |
Not Specified |
Emaps: |
EMAPS:3703820 |
Pattern: |
Regionally restricted |
Stage: |
TS20 |
Assay Id: |
MGI:6514794 |
Age: |
embryonic day 12.5 |
|
Note: |
Expression throughout cytoplasm, with intense expression on apical surfaces of some epithelia. |
Specimen Label: |
2H |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6514773 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2021-04-02 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3703920 |
Pattern: |
Not Specified |
Stage: |
TS20 |
Assay Id: |
MGI:6514794 |
Age: |
embryonic day 12.5 |
|
|
Specimen Label: |
2H |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6514773 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2021-04-02 |
Strength: |
Strong |
Sex: |
Not Specified |
Emaps: |
EMAPS:3704020 |
Pattern: |
Regionally restricted |
Stage: |
TS20 |
Assay Id: |
MGI:6514794 |
Age: |
embryonic day 12.5 |
|
Note: |
Expession distributed throughout cytoplasm, with strong expression on both apical and basal sides of nuclei. |
Specimen Label: |
2G |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6514773 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2021-04-02 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:3704023 |
|
Stage: |
TS23 |
Assay Id: |
MGI:6514794 |
Age: |
embryonic day 15.5 |
|
Note: |
Apical expression was found to be nonspecific. |
Specimen Label: |
2I |
Detected: |
false |
Specimen Num: |
3 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6514773 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2021-04-02 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3704120 |
Pattern: |
Not Specified |
Stage: |
TS20 |
Assay Id: |
MGI:6514794 |
Age: |
embryonic day 12.5 |
|
|
Specimen Label: |
2G |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6388603 |
Assay Type: |
RNA in situ |
Annotation Date: |
2020-02-10 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3809624 |
Pattern: |
Non-Uniform |
Stage: |
TS24 |
Assay Id: |
MGI:6389107 |
Age: |
embryonic day 16.5 |
Image: |
4O |
Note: |
The majority of signal was in the cranial neural crest-derived mesenchymal cells surrounding the muscle fibers. Little expression was detectable in the myogenic fibers. |
Specimen Label: |
4O |
Detected: |
true |
Specimen Num: |
3 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6388603 |
Assay Type: |
RNA in situ |
Annotation Date: |
2020-02-10 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3809524 |
Pattern: |
Non-Uniform |
Stage: |
TS24 |
Assay Id: |
MGI:6389107 |
Age: |
embryonic day 16.5 |
Image: |
4M |
Note: |
The majority of signal was in the cranial neural crest-derived mesenchymal cells surrounding the muscle fibers. Little expression was detectable in the myogenic fibers. |
Specimen Label: |
4M |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6514773 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2021-04-02 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3817520 |
Pattern: |
Not Specified |
Stage: |
TS20 |
Assay Id: |
MGI:6514794 |
Age: |
embryonic day 12.5 |
|
|
Specimen Label: |
E12.5 not shown |
Detected: |
true |
Specimen Num: |
4 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6514773 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2021-04-02 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:3817523 |
|
Stage: |
TS23 |
Assay Id: |
MGI:6514794 |
Age: |
embryonic day 15.5 |
|
|
Specimen Label: |
E15.5 not shown |
Detected: |
false |
Specimen Num: |
5 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:6514773 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2021-04-02 |
Strength: |
Absent |
Sex: |
Not Specified |
Emaps: |
EMAPS:3817526 |
|
Stage: |
TS26 |
Assay Id: |
MGI:6514794 |
Age: |
embryonic day 18.5 |
|
|
Specimen Label: |
E18.5 not shown |
Detected: |
false |
Specimen Num: |
6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ornitz DM |
Year: |
1996 |
Journal: |
J Biol Chem |
Title: |
Receptor specificity of the fibroblast growth factor family. |
Volume: |
271 |
Issue: |
25 |
Pages: |
15292-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Inagaki T |
Year: |
2005 |
Journal: |
Cell Metab |
Title: |
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. |
Volume: |
2 |
Issue: |
4 |
Pages: |
217-25 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stark KL |
Year: |
1991 |
Journal: |
Development |
Title: |
FGFR-4, a new member of the fibroblast growth factor receptor family, expressed in the definitive endoderm and skeletal muscle lineages of the mouse. |
Volume: |
113 |
Issue: |
2 |
Pages: |
641-51 |
|
•
•
•
•
•
|
Publication |
First Author: |
Olson DC |
Year: |
1998 |
Journal: |
Cell Growth Differ |
Title: |
Fibroblast growth factor receptor 4, implicated in progression of islet cell carcinogenesis by its expression profile, does not contribute functionally. |
Volume: |
9 |
Issue: |
7 |
Pages: |
557-64 |
|
•
•
•
•
•
|
Publication |
First Author: |
Grabner A |
Year: |
2017 |
Journal: |
Sci Rep |
Title: |
FGF23/FGFR4-mediated left ventricular hypertrophy is reversible. |
Volume: |
7 |
Issue: |
1 |
Pages: |
1993 |
|
•
•
•
•
•
|
Publication |
First Author: |
Taylor A |
Year: |
2019 |
Journal: |
Sci Rep |
Title: |
FGFR4 does not contribute to progression of chronic kidney disease. |
Volume: |
9 |
Issue: |
1 |
Pages: |
14023 |
|
•
•
•
•
•
|
Publication |
First Author: |
Matsushita Y |
Year: |
2023 |
Journal: |
Nat Commun |
Title: |
Bone marrow endosteal stem cells dictate active osteogenesis and aggressive tumorigenesis. |
Volume: |
14 |
Issue: |
1 |
Pages: |
2383 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stone JS |
Year: |
2018 |
Journal: |
J Assoc Res Otolaryngol |
Title: |
Characterization of Adult Vestibular Organs in 11 CreER Mouse Lines. |
Volume: |
19 |
Issue: |
4 |
Pages: |
381-399 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
244
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
215
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
140
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
233
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
191
|
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
203
|
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Vanhaesebroeck B |
Year: |
1999 |
Journal: |
Exp Cell Res |
Title: |
Signaling by distinct classes of phosphoinositide 3-kinases. |
Volume: |
253 |
Issue: |
1 |
Pages: |
239-54 |
|
•
•
•
•
•
|
Publication |
First Author: |
Huh SH |
Year: |
2015 |
Journal: |
Elife |
Title: |
Cochlear progenitor number is controlled through mesenchymal FGF receptor signaling. |
Volume: |
4 |
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Ulaganathan VK |
Year: |
2015 |
Journal: |
Nature |
Title: |
Germline variant FGFR4  p.G388R exposes a membrane-proximal STAT3 binding site. |
Volume: |
528 |
Issue: |
7583 |
Pages: |
570-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kogan D |
Year: |
2018 |
Journal: |
J Clin Invest |
Title: |
STAT3-enhancing germline mutations contribute to tumor-extrinsic immune evasion. |
Volume: |
128 |
Issue: |
5 |
Pages: |
1867-1872 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wu AL |
Year: |
2011 |
Journal: |
PLoS One |
Title: |
FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways. |
Volume: |
6 |
Issue: |
3 |
Pages: |
e17868 |
|
•
•
•
•
•
|
Publication |
First Author: |
Czaya B |
Year: |
2022 |
Journal: |
Elife |
Title: |
Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling. |
Volume: |
11 |
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Zhao P |
Year: |
2006 |
Journal: |
J Biol Chem |
Title: |
Fgfr4 is required for effective muscle regeneration in vivo. Delineation of a MyoD-Tead2-Fgfr4 transcriptional pathway. |
Volume: |
281 |
Issue: |
1 |
Pages: |
429-38 |
|
•
•
•
•
•
|
Publication |
First Author: |
deLapeyrière O |
Year: |
1993 |
Journal: |
Development |
Title: |
Expression of the Fgf6 gene is restricted to developing skeletal muscle in the mouse embryo. |
Volume: |
118 |
Issue: |
2 |
Pages: |
601-11 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yu S |
Year: |
2004 |
Journal: |
Lab Invest |
Title: |
Distinct transcriptional control and action of fibroblast growth factor receptor 4 in differentiating skeletal muscle cells. |
Volume: |
84 |
Issue: |
12 |
Pages: |
1571-80 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wu X |
Year: |
2010 |
Journal: |
J Biol Chem |
Title: |
FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation. |
Volume: |
285 |
Issue: |
8 |
Pages: |
5165-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wang C |
Year: |
2014 |
Journal: |
Curr Mol Med |
Title: |
Hepatocyte FRS2α is essential for the endocrine fibroblast growth factor to limit the amplitude of bile acid production induced by prandial activity. |
Volume: |
14 |
Issue: |
6 |
Pages: |
703-711 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang X |
Year: |
2006 |
Journal: |
J Biol Chem |
Title: |
Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. |
Volume: |
281 |
Issue: |
23 |
Pages: |
15694-700 |
|
•
•
•
•
•
|
Publication |
First Author: |
Burgess WH |
Year: |
1989 |
Journal: |
Annu Rev Biochem |
Title: |
The heparin-binding (fibroblast) growth factor family of proteins. |
Volume: |
58 |
|
Pages: |
575-606 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wilkie AO |
Year: |
1995 |
Journal: |
Curr Biol |
Title: |
Functions of fibroblast growth factors and their receptors. |
Volume: |
5 |
Issue: |
5 |
Pages: |
500-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Thomas KA |
Year: |
1988 |
Journal: |
Trends Biochem Sci |
Title: |
Transforming potential of fibroblast growth factor genes. |
Volume: |
13 |
Issue: |
9 |
Pages: |
327-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ornitz DM |
Year: |
2001 |
Journal: |
Genome Biol |
Title: |
Fibroblast growth factors. |
Volume: |
2 |
Issue: |
3 |
Pages: |
REVIEWS3005 |
|
•
•
•
•
•
|
Publication |
First Author: |
Plotnikov AN |
Year: |
2000 |
Journal: |
Cell |
Title: |
Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. |
Volume: |
101 |
Issue: |
4 |
Pages: |
413-24 |
|
•
•
•
•
•
|
Publication |
First Author: |
Blaber M |
Year: |
1996 |
Journal: |
Biochemistry |
Title: |
X-ray crystal structure of human acidic fibroblast growth factor. |
Volume: |
35 |
Issue: |
7 |
Pages: |
2086-94 |
|
•
•
•
•
•
|
Publication |
First Author: |
Vlodavsky I |
Year: |
1990 |
Journal: |
Cancer Metastasis Rev |
Title: |
Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. |
Volume: |
9 |
Issue: |
3 |
Pages: |
203-26 |
|
•
•
•
•
•
|
Publication |
First Author: |
Green PJ |
Year: |
1996 |
Journal: |
Bioessays |
Title: |
Promiscuity of fibroblast growth factor receptors. |
Volume: |
18 |
Issue: |
8 |
Pages: |
639-46 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yardley N |
Year: |
2012 |
Journal: |
Dev Biol |
Title: |
FGF signaling transforms non-neural ectoderm into neural crest. |
Volume: |
372 |
Issue: |
2 |
Pages: |
166-77 |
|
•
•
•
•
•
|
Publication |
First Author: |
Böttcher RT |
Year: |
2005 |
Journal: |
Endocr Rev |
Title: |
Fibroblast growth factor signaling during early vertebrate development. |
Volume: |
26 |
Issue: |
1 |
Pages: |
63-77 |
|
•
•
•
•
•
|
Publication |
First Author: |
Koga C |
Year: |
1999 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Characterization of a novel member of the FGF family, XFGF-20, in Xenopus laevis. |
Volume: |
261 |
Issue: |
3 |
Pages: |
756-65 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nakamizo S |
Year: |
2013 |
Journal: |
Skin Pharmacol Physiol |
Title: |
Topical treatment with basic fibroblast growth factor promotes wound healing and barrier recovery induced by skin abrasion. |
Volume: |
26 |
Issue: |
1 |
Pages: |
22-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kumar SB |
Year: |
2013 |
Journal: |
Curr Pharm Des |
Title: |
Fibroblast growth factor receptor inhibitors. |
Volume: |
19 |
Issue: |
4 |
Pages: |
687-701 |
|
•
•
•
•
•
|
Publication |
First Author: |
Amaya E |
Year: |
1991 |
Journal: |
Cell |
Title: |
Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos. |
Volume: |
66 |
Issue: |
2 |
Pages: |
257-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Borland CZ |
Year: |
2001 |
Journal: |
Bioessays |
Title: |
Fibroblast growth factor signaling in Caenorhabditis elegans. |
Volume: |
23 |
Issue: |
12 |
Pages: |
1120-30 |
|
•
•
•
•
•
|
Publication |
First Author: |
Coumoul X |
Year: |
2003 |
Journal: |
Birth Defects Res C Embryo Today |
Title: |
Roles of FGF receptors in mammalian development and congenital diseases. |
Volume: |
69 |
Issue: |
4 |
Pages: |
286-304 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sutherland D |
Year: |
1996 |
Journal: |
Cell |
Title: |
branchless encodes a Drosophila FGF homolog that controls tracheal cell migration and the pattern of branching. |
Volume: |
87 |
Issue: |
6 |
Pages: |
1091-101 |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
128
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
734
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
156
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
305
|
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Ogawa Y |
Year: |
2007 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
BetaKlotho is required for metabolic activity of fibroblast growth factor 21. |
Volume: |
104 |
Issue: |
18 |
Pages: |
7432-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shin DJ |
Year: |
2009 |
Journal: |
J Biol Chem |
Title: |
FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action. |
Volume: |
284 |
Issue: |
17 |
Pages: |
11110-20 |
|
•
•
•
•
•
|
Publication |
First Author: |
Potthoff MJ |
Year: |
2011 |
Journal: |
Cell Metab |
Title: |
FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway. |
Volume: |
13 |
Issue: |
6 |
Pages: |
729-38 |
|
•
•
•
•
•
|
Publication |
First Author: |
Huang X |
Year: |
2006 |
Journal: |
Mol Carcinog |
Title: |
Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis. |
Volume: |
45 |
Issue: |
12 |
Pages: |
934-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kong B |
Year: |
2012 |
Journal: |
Hepatology |
Title: |
Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice. |
Volume: |
56 |
Issue: |
3 |
Pages: |
1034-43 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gattineni J |
Year: |
2014 |
Journal: |
Am J Physiol Renal Physiol |
Title: |
Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4. |
Volume: |
306 |
Issue: |
3 |
Pages: |
F351-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Singh S |
Year: |
2016 |
Journal: |
Kidney Int |
Title: |
Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease. |
Volume: |
90 |
Issue: |
5 |
Pages: |
985-996 |
|
•
•
•
•
•
|
Publication |
First Author: |
Han X |
Year: |
2020 |
Journal: |
J Mol Cell Cardiol |
Title: |
FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in mice. |
Volume: |
138 |
|
Pages: |
66-74 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wu X |
Year: |
2009 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice. |
Volume: |
106 |
Issue: |
34 |
Pages: |
14379-84 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kaneko KJ |
Year: |
2007 |
Journal: |
Genesis |
Title: |
Transcription factor TEAD2 is involved in neural tube closure. |
Volume: |
45 |
Issue: |
9 |
Pages: |
577-87 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhou C |
Year: |
2023 |
Journal: |
Biochim Biophys Acta Mol Basis Dis |
Title: |
Fibroblast growth factor 21 ameliorates cholestatic liver injury via a hepatic FGFR4-JNK pathway. |
Volume: |
1870 |
Issue: |
1 |
Pages: |
166870 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bottaro DP |
Year: |
1990 |
Journal: |
J Biol Chem |
Title: |
Characterization of the receptor for keratinocyte growth factor. Evidence for multiple fibroblast growth factor receptors. |
Volume: |
265 |
Issue: |
22 |
Pages: |
12767-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Crawford MJ |
Year: |
1997 |
Journal: |
Mamm Genome |
Title: |
Human and murine PTX1/Ptx1 gene maps to the region for Treacher Collins syndrome. |
Volume: |
8 |
Issue: |
11 |
Pages: |
841-5 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
386
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
822
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
833
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
822
|
Fragment?: |
false |
|
•
•
•
•
•
|